Primary Oral Mucosal Melanoma: A Case Series

Author(s):  
Ankita Chugh ◽  
Yogesh Mittal ◽  
Shruti Khatana ◽  
Aditi Mishra ◽  
Shilajit Bhattacharya ◽  
...  
2017 ◽  
Vol 2 ◽  
pp. 2057178X1770581
Author(s):  
RAG Khammissa ◽  
M Altini ◽  
S Meer ◽  
J Lemmer ◽  
L Feller

2021 ◽  
Vol 13 ◽  
Author(s):  
Carla Aguiar Andrade ◽  
Cláudia Cardoso de Macedo Oliveira ◽  
Eduardo Vinícius Mendes Roncada ◽  
Diogo Gonçalves Ribeiro

2012 ◽  
Vol 16 (2) ◽  
pp. 135-142 ◽  
Author(s):  
Suzan Abu-Abed ◽  
Nancy Pennell ◽  
Teresa Petrella ◽  
Frances Wright ◽  
Arun Seth ◽  
...  

Background: Recently characterized KIT (CD117) gene mutations have revealed new pathways involved in melanoma pathogenesis. In particular, certain subtypes harbor mutations similar to those observed in gastrointestinal stromal tumors, which are sensitive to treatment with tyrosine kinase inhibitors. Objective: The purpose of this study was to characterize KIT gene mutations and patterns of protein expression in mucosal and acral melanoma. Methods: Formalin-fixed, paraffin-embedded tissues were retrieved from our archives. Histologic assessment included routine hematoxylin-eosin stains and immunohistochemical staining for KIT. Genomic DNA was used for polymerase chain reaction-based amplification of exons 11 and 13. Results: We identified 59 acral and mucosal melanoma cases, of which 78% showed variable levels of KIT expression. Sequencing of exons 11 and 13 was completed on all cases, and 4 (6.8%) mutant cases were isolated. Conclusion: We successfully optimized conditions for the detection of KIT mutations and showed that 8.6% of mucosal and 4.2% of acral melanoma cases at our institution harbor KIT mutations; all mutant cases showed strong, diffuse KIT protein expression. Our case series represents the first Canadian study to characterize KIT gene mutations and patterns of protein expression in acral and mucosal melanoma.


2019 ◽  
Vol 22 (12) ◽  
pp. 1752 ◽  
Author(s):  
MC Nwoga ◽  
OA Effiom ◽  
BF Adeyemi ◽  
OO Soyele ◽  
CU Okwuosa

2020 ◽  
Vol 15 (4) ◽  
pp. 556-557
Author(s):  
Chieh-Wei Lin ◽  
Yi-Pang Lee ◽  
Ming-Jay Hwang ◽  
Chun-Pin Chiang

2017 ◽  
Vol 2017 ◽  
pp. 1-7 ◽  
Author(s):  
Liviu Feller ◽  
Razia A. G. Khammissa ◽  
Johan Lemmer

Oral mucosal melanoma is an uncommon, usually heavily melanin-pigmented, but occasionally amelanotic aggressive tumour with a poor prognosis. Despite radical surgery, radiotherapy, or chemotherapy, local recurrence and distant metastasis are frequent. Microscopical examination is essential for diagnosis, and routine histological staining must be supplemented by immunohistochemical studies. The aetiology is unknown, the pathogenesis is poorly understood, and the 5-year survival rate rarely exceeds 30%. In most cases, oral mucosal melanoma arises from epithelial melanocytes in the basal layer of the epithelium and less frequently from immature melanocytes arrested in the lamina propria. In both cases the melanocytes undergo malignant transformation, invade deeper tissues, and metastasize to regional lymph nodes and to distant sites. Very rarely metastasis from skin melanoma may give rise to oral mucosal melanoma that may be mistaken for primary oral mucosal melanoma. The pathogenesis of oral mucosal melanoma is complex involving multiple interactions between cytogenetic factors including dysregulation of the cKit signalling pathways, cell cycle, apoptosis, and cell-to-cell interactions on the one hand and melanin itself, melanin intermediates, and local microenvironmental agents regulating melanogenesis on the other hand. The detailed mechanisms that initiate the malignant transformation of oral melanocytes and thereafter sustain and promote the process of melanomagenesis are unknown.


Sign in / Sign up

Export Citation Format

Share Document